Dr. Schneider's laboratory study innate immunity and microbial pathogenesis.

Dr. Schatzberg's current research is in biological bases of depressive disorders, glucocorticoid/dopamine interactions in delusional depression, and pharmacologic treatment of depressive disorders.

Dr. Sapolsky's current studies are in neuron death, stress, and gene therapy.

Dr. Sarnow's laboratory has been been studying the mechanism by which a liver-specific microRNA, miR-122, regulates the amplification of the hepatitis C virus (HCV) genome in cultured cells.

Dr. Julia Salzman's lab is primarily a computational data science laboratory focused on studying RNA biology with a secondary focus on validation and novel experimental design to enable statistical analysis of RNA expression.

Dr. Santiago's research focuses on the study of microscale transport phenomena including electrokinetic flow, electrohydrodynamic instabilities, and general convective-diffusion-electromigration processes.

Dr. Sage's research program focuses on the mechanisms that control the proliferation of mammalian cells under normal and pathological conditions (regeneration, cancer), with a particular emphasis on stem cells and gene regulatory networks.

Dr. Saberi research interests include algorithms, approximation algorithms, and algorithmic aspects of games, markets, and networks.

Dr. Rutt is presently interested in developing and using in-vivo ultra-high field (e.g. 7 Tesla) Magnetic Resonance techniques to study important human diseases.

Dr. Sabatti's laboratory current studies are in the statistical models and reasoning are key to their understanding of the genetic basis of human traits.